Use of biosimilars in inflammatory bowel diseases: A survey among the clinicians members of the Italian Group for the Study of Inflammatory Bowel Disease (IGIBD)

Angelo Viscido, Andrea Buda, Flavio Caprioli, Mariabeatrice Principi, Marco Daperno, Alessandro Armuzzi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)928-930
JournalDigestive and Liver Disease
Issue number8
Publication statusPublished - 2020


  • Biosimilars
  • Inflammatory bowel diseases
  • Questionnaire
  • Survey

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this